CDH1 and neoplasm: E-Cadherin has been classified as a tumour suppressor and diminished E-Cadherin expression in epithelial cancer cells has been related to the process of EMT in multiple carcinomas, including breast cancer [19, 20] and to the acquisition of chemoresistance [21, 22].